Karin Skogholm

Title: Inventor Spotlight: Karin Skogholm

Introduction

Karin Skogholm is an innovative inventor based in Södertälje, Sweden, with a remarkable portfolio that includes three patents. Her work primarily focuses on the development of pharmaceutical compounds aimed at addressing significant medical challenges.

Latest Patents

Karin's latest patents showcase her groundbreaking contributions to the field of pharmaceuticals. The first patent details new compounds or salts, solvates, or solvated salts, along with processes for their preparation. It also highlights pharmaceutical compositions containing these compounds and their therapeutic uses. The second patent introduces N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives designated for the treatment of pain. This invention includes pharmaceutical compositions containing these compounds and processes for their preparation, offering valuable new intermediates for enhanced therapeutic applications.

Career Highlights

Karin Skogholm is currently affiliated with AstraZeneca AB, a leading global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines. Her tenure at AstraZeneca has enabled her to leverage her expertise in medicinal chemistry and pharmaceutical development to create impactful solutions for patients.

Collaborations

Throughout her career, Karin has collaborated with notable colleagues, including Yevgeni Besidski and Inger Kers. These collaborations have fostered an environment of innovation, enhancing the scope and impact of their research endeavors.

Conclusion

Karin Skogholm exemplifies the spirit of innovation in the pharmaceutical field. With her impressive portfolio of patents and her affiliation with AstraZeneca AB, she continues to contribute to the fight against pain and other medical conditions. Her work not only showcases her expertise as an inventor but also represents a significant advancement in the therapeutic landscape.